AADAT-Driven Metabolic Control of Malate and CoQ <sub>10</sub> Shapes Immune Evasion in Triple-Negative Breast Cancer
Megha Chatterjee(Baylor College of Medicine), Arun Sreekumar(University of Michigan–Ann Arbor), Hugo Villanueva(Baylor College of Medicine), Vasanta Putluri(Baylor College of Medicine), Franklin Gu(Baylor College of Medicine), Yang Gao(Breast Center), Balasubramanyam Karanam(Tuskegee University), Badrajee Piyarathna(Baylor College of Medicine), Sung Yun Jung, Mary K. McKenna(Baylor College of Medicine), Nagi S. Chandandeep(Baylor College of Medicine), Arundati Rao(Baylor Scott & White Medical Center - Temple), Ahmed Elkhanany(University of Alabama at Birmingham), Jaya Ruth Asirvatham(Baylor Scott & White Medical Center - Temple), Carl Morrison(Cancer Genetics (United States)), W Zhang(Baylor College of Medicine), Liqun Yu(Baylor College of Medicine), Irwin J. Kurland(Albert Einstein College of Medicine), Xiang H.-F. Zhang(Texas Medical Center), Susmita Samanta(Baylor College of Medicine), Gokul M. Das(Roswell Park Comprehensive Cancer Center), Angela R. Omilian(Roswell Park Comprehensive Cancer Center), Lin Tian(Sichuan University), YUNPING QIU(Albert Einstein College of Medicine), Dana Varghese(Baylor College of Medicine), Sai Manohar Thota(Baylor College of Medicine), Qian Zhu(Baylor College of Medicine), Andrew Davis(Washington University in St. Louis), Carolina Gutierrez(Baylor College of Medicine), Nagireddy Putluri(Baylor College of Medicine), Lynette Ewura Esi Fordwuo(Texas Children's Hospital), Jun Hyoung Park(Baylor College of Medicine), Christine Ambrosone(Roswell Park Comprehensive Cancer Center), Benny Abraham Kaipparettu(Baylor Genetics), Brian Wesley Simons(Baylor College of Medicine), E. Seeley(Austin College)
Cited by 0
Related Papers
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020
|Journal of the National Comprehensive Cancer Network|2020|507